Novavax (NVAX) to Report Q3 Earnings: What's in the Cards?

Published on November 1, 2021

On Novavax's (NVAX) upcoming third-quarter earnings call, investor focus is likely to be on the company's progress with its COVID-19 vaccine candidate NVX-CoV2373.

Continue reading on website
Other news

B&G Foods (BGS) Queued Up for Q3 Earnings: Key Aspects to Note

November 1, 2021
B&G Foods' (BGS) third-quarter performance is likely to have been affected by higher input costs, such as raw materials and transportation.

Alliant Energy (LNT) to Post Q3 Earnings: What's in the Cards?

November 1, 2021
Higher demand, expanding customer base and efforts to lower operating expenses are likely to benefit Alliant Energy's (LNT) third-quarter results.